Molecular and cellular determinants of lung endothelial cell heterogeneity

Chest

Volumn 128, Issue 6 SUPPL., 2005, Pages 558S-564S

  Stevens, Troy ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Epigenetic; Lectins; Permeability; Phenotype; Pulmonary hypertension

Indexed keywords

BLOOD VESSEL; CELL HETEROGENEITY; CELL HYPERPLASIA; CONFERENCE PAPER; ENDOTHELIUM CELL; FATALITY; HUMAN; LUNG ENDOTHELIUM; MOLECULAR BIOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 30144433844     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.6_suppl.558S     Document Type: Conference Paper

References (29)

1. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998; 352:719-725
2. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:13S-24S
3. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004; 351:1655-1665
4. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43:5S-12S
5. Barst RJ. Medical therapy of pulmonary hypertension: an overview of treatment and goals. Clin Chest Med 2001; 22:509-515
6. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004; 109:159-165
7. Rabinovitch M. Pulmonary hypertension: pathophysiology as a basis for clinical decision making. J Heart Lung Transplant 1999; 18:1041-1053
8. Cool CD, Stewart JS, Werahera P, et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999; 155:411-419
9. Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994; 144:275-285
10. Tuder RM, Voelkel NF. Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion. Am J Pathol 2001; 159:382-383
11. Tuder RM, Cool CD, Yeager M, et al. The pathobiology of pulmonary hypertension: endothelium. Clin Chest Med 2001; 22:405-418
12. Gebb S, Stevens T. On lung endothelial cell heterogeneity. Microvasc Res 2004; 68:1-12
13. Stevens T, Rosenberg R, Aird W, et al. NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am J Physiol Cell Physiol 2001; 281:C1422-C1433
14. Garlanda C, Dejana E. Heterogeneity of endothelial cells: specific markers. Arterioscler Thromb Vasc Biol 1997; 17:1193-1202
15. Fagan KA, McMurtry I, Rodman DM. Nitric oxide synthase in pulmonary hypertension: lessons from knockout mice. Physiol Res 2000; 49:539-548
16. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333:214-221
17. Xu W, Kaneko FT, Zheng S, et al. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 2004; 18:1746-1748
18. Tuder RM, Cool CD, Geraci MW, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 1999; 159:1925-1932
19. Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327:70-75
20. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328:1732-1739
21. Chetham PM, Babal P, Bridges JP, et al. Segmental regulation of pulmonary vascular permeability by store-operated Ca2+ entry. Am J Physiol 1999; 276:L41-L50
22. Kelly JJ, Moore TM, Babal P, et al. Pulmonary microvascular and macrovascular endothelial cells: differential regulation of Ca2+ and permeability. Am J Physiol 1998; 274:L810-L819
23. Parker JC, Yoshikawa S. Vascular segmental permeabilities at high peak inflation pressure in isolated rat lungs. Am J Physiol Lung Cell Mol Physiol 2002; 283:L1203-L1209
24. Quadri SK, Bhattacharjee M, Parthasarathi K, et al. Endothelial barrier strengthening by activation of focal adhesion kinase. J Biol Chem 2003; 278:13342-13349
25. Safdar Z, Wang P, Ichimura H, et al. Hyperosmolarity enhances the lung capillary barrier. J Clin Invest 2003; 112:1541-1549
26. King J, Hamil T, Creighton J, et al. Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res 2004; 67:139-151
27. Taraseviciene-Stewart L, Kasahara Y, Alger L, et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001; 15:427-438
28. Seki T, Yun J, Oh SP. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 2003; 93:682-689
29. Seki T, Hong KH, Yun J, et al. Isolation of a regulatory region of activin receptor-like kinase 1 gene sufficient for arterial endothelium-specific expression. Circ Res 2004; 94:e72-e77